PBAC recommends 3 new hepatitis C drugs In HepatitisApril 28, 20151 Min Read P Hepatitis SA, April 2015 The Pharmaceutical Benefit Advisory Committee has recommended three new drugs for treatment of hepatitis C. Read more here Australia daclatasvir hepatitis hepatitis C (HCV) Hepatitis SA ledipasvir outcomes PBAC Pharmaceutical Benefits Scheme (PBS) sofosbuvir treatment FacebookXReddit
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence June 8, 2023 T
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia May 30, 2023 O